Bio-Thera will obtain an upfront payment of $21m and could earn up to $143.5m in development and commercial milestones.

Accord BioPharma Inc., the U.S. specialty division of Intas Pharmaceuticals Ltd., has reached an exclusive commercialization and license agreement with Bio-Thera Solutions for BAT2506, a biosimilar ...

I would never want to do a commercial unless I could do it on my own terms, unless it could be genuinely funny and creative.” ...

NASCAR driver Ross Chastain is featured in a Super Bowl commercial this year thanks to Busch Light. (Busch Light) ...

Former Miami-based World Bank leader laments as the Trump administration pauses foreign assistance programs | Opinion ...

Chinas top economic planning agency announced plans to scale back subsidies for renewable energy projects after a record ...

Not for distribution to U.S. news wire services or for dissemination in the United StatesVANCOUVER, British Columbia, Feb. 10, 2025 (GLOBE ...

The court filings show that investigators believe the teen was held in four different South Shore communities before she was ...

The Indonesian government remains confident that the US’ plans to withdraw from the global climate pact will have little to ...

The climate crisis isn’t just about the availability and cost of housing. It's also about location and quality.

Mexico has repealed import restrictions on genetically modified corn for human, livestock and industrial uses following a US ...